Biogen (BIIB) EV to EBITDA (2009 - 2026)

Biogen has reported EV to EBITDA for 18 years, with the latest figure at 47.54 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 142.21% year-over-year to 47.54 in Q2 2026; TTM through Jun 2026 was 19.19, a 19.23% increase from a year earlier, with the FY2025 full-year figure at 25.98, up 47.27% from the prior year.
• EV to EBITDA was 47.54 for Q2 2026 at Biogen, up from 80.42 in the prior quarter.
• The five-year high for EV to EBITDA was 304.75 in Q2 2023, with the low at 391.74 in Q1 2024.
• Average EV to EBITDA over 5 years is 3.44, with a median of 41.78 recorded in 2023.
• The largest YoY upside for EV to EBITDA was 865.74% in 2023 against a maximum downside of 453.65% in 2023.
• Over 5 years, EV to EBITDA stood at 79.52 in 2022, then surged by 259.17% to 285.63 in 2023, then slumped by 123.88% to 68.22 in 2024, then surged by 41.47% to 39.93 in 2025, then decreased by 19.06% to 47.54 in 2026.
• The last three EV to EBITDA figures came in at 47.54 (Q2 2026), 80.42 (Q1 2026), and 39.93 (Q4 2025), per Business Quant data.